1–10 of 21 results for progression
Association Between Dysfunctional Complement Factor I: Rare Variant Status and Progression to Advanced AMD Outcomes
Johanna M. Seddon, MD, ScM, FARVO, FASRS
Annual Meeting Talks
2022
Relationship Between Number of Intermediate-Large Drusen and Geographic Atrophy Lesion Growth Rate in the Sham Groups of the DERBY, OAKS, and FILLY Trials
Eleonora Lad, MD, PhD
Early Progression of Atrophy in AMD: Post Hoc Analysis From the GATHER1 Study
David R Lally, MD
Dexamethasone Implant Appears to Slow Diabetic Retinopathy Progression: A Retrospective Analysis of the MEAD Study
On Demand Cases, Courses, and Papers
Machine and Deep Learning (AI) Algorithms for GA Identification and Prediction of Progression to GA from Intermediate AMD: The Future of Dry AMD Management
Updates from the Field
2023
Impact of Intravitreal Anti-VEGF Therapy for Severe Non-Proliferative Diabetic Retinopathy (NPDR): Analyses Through a Monte-Carlo Simulation Model
Andrew A. Moshfeghi, MD, MBA, FASRS
2021
Dual Anti-platelet Therapy Decelerates the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Yodpong Chantarasorn, MD
Machine Learning Enabled Outer Retinal OCT Biomarker Extraction for Identification of High-Risk AMD Eyes for Subfoveal Geographic Atrophy Progression
Kubra Sarici, MD
Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Association of Ocular Antihypertensive Medications and the Development and Progression of Macular Degeneration in a US Insurance Claims Database
Thomas J Wubben, MD, PhD
2020